You have probably seen that https://www.certara.com/software/trial-simulator was released last month.
I am pleased to announce that Certara University has created a short course on What is New in TS2.3 that is now publically available. This is a complimentary course although a login to Certara University is required. The course is designed for users familiar with prior versions of TS although new users could also benefit of some videos that describe the tool in detail. You can register in the link below. https://www.certarauniversity.com/learn/course/external/view/elearning/418/115-od-what-is-new-in-trial-simulator-23 There are also some recent webinars e.g. https://www.certara.com/webinar-archive/using-realistic-covariates-with-new-trial-simulator-to-optimize-meropenem-dosing-in-renally-impaired-children/?UTM_LeadSource=11272018 And an example guide : Trial Simulator for NONMEM Modelers you can access here https://www.certara.com/trial-simulator-examples-guide/ Lastly we recommend that anyone with questions or comments about the guide to use the online forum. Please join and follow this topic, Thank you. https://support.certara.com/forums/forum/36-trial-simulation/ Best regards, Simon. Simon DAVIS Senior Scientific Consultant https://www.certara.com/wp-content/uploads/Resources/Brochures/BR_TrialSimulator.pdf https://s3.amazonaws.com/certara-training/LMS/website/files/phoenix/schedule/2019+Training+Calendar+by+Location.pdf NOTICE: The information contained in this electronic mail message is intended only for the personal and confidential use of the designated recipient(s) named above. This message may be an attorney-client communication, may be protected by the work product doctrine, and may be subject to a protective order. As such, this message is privileged and confidential. If the reader of this message is not the intended recipient or an agent responsible for delivering it to the intended recipient, you are hereby notified that you have received this message in error and that any review, dissemination, distribution, or copying of this message is strictly prohibited. If you have received this communication in error, please notify us immediately by telephone and e-mail and destroy any and all copies of this message in your possession (whether hard copies or electronically stored copies). Thank you. buSp9xeMeKEbrUze
